Concepedia

John L. Mershon

JL

22

Publications

1.9K

Citations

19

H-Index

1990

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Pittsburgh

University of Cincinnati

University of Cincinnati Medical Center

University of California San Diego

John L. Mershon is an author at Eli Lilly (United States) specializing in medicine, health sciences, and physiology.

Top concepts

Publications per year

1990–2021

22

Publications

22

Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Silvana Martino, Jane A. Cauley, Elizabeth Barrett‐Connor et al. · JNCI Journal of the National Cancer Institute · 2004 · 683 citations · Full text

Tibia shaft fractures: costly burden of nonunions

Evgeniya Antonova, Trong Kim Le, Russel Burge et al. · BMC Musculoskeletal Disorders · 2013 · 377 citations · Full text

Safety assessment of raloxifene over eight years in a clinical trial setting

Silvana Martino, Damon Disch, Sherie A. Dowsett et al. · Current Medical Research and Opinion · 2005 · 112 citations

Prolactin is a local growth factor in rat mammary tumors.

John L. Mershon, Walter Sall, NA Mitchner et al. · Endocrinology · 1995 · 68 citations

, , +10

Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis Categorized by Breast Cancer Risk

Marc E. Lippman, Steven R. Cummings, Damon Disch et al. · Clinical Cancer Research · 2006 · 65 citations

Rows per page

1–5 of 22